Chemiluminescence involves the emission of light from a chemical reaction without the generation of significant heat. It has various applications including chemiluminescent immunoassays, DNA hybridization detection, and analysis in forensics and food. The three major chemiluminescent technologies are those using acridinium ester labels, horseradish peroxidase labels, and alkaline phosphatase labels. Chemiluminescence provides advantages such as wide dynamic range and high sensitivity and has been used in clinical testing, research, and cellular and gene-based assays.
intoduction to lumiscence
introduction and principle of chemilumiscence
different types of lumiscence
detail of the electrochemilumiscence, working, principle, instrumentation, measurin.
application in medical field
difference between chemilumiscence and elecrochemiluminescence
Use of laboratory instruments and specimen processing equipment to perform clinical laboratory assays with only minimal involvement of technologist .
Automation in clinical laboratory is a process by which analytical instruments perform many tests with the least involvement of an analyst.
The International Union of Pure and Applied Chemistry (IUPAC) define automation as "The replacement of human manipulative effort and facilities in the performance of a given process by mechanical and instrumental devices that are regulated by feedback of information so that an apparatus is self-monitoring or self adjusting”.
This is a powerpoint of automation in clinical chemistry. This comprises the definition of automation, steps of the analytical process, and detail about the continuous flow analyzer.Thus, this will be helpful for the students of medical laboratory, biochemistry students and teachers.
intoduction to lumiscence
introduction and principle of chemilumiscence
different types of lumiscence
detail of the electrochemilumiscence, working, principle, instrumentation, measurin.
application in medical field
difference between chemilumiscence and elecrochemiluminescence
Use of laboratory instruments and specimen processing equipment to perform clinical laboratory assays with only minimal involvement of technologist .
Automation in clinical laboratory is a process by which analytical instruments perform many tests with the least involvement of an analyst.
The International Union of Pure and Applied Chemistry (IUPAC) define automation as "The replacement of human manipulative effort and facilities in the performance of a given process by mechanical and instrumental devices that are regulated by feedback of information so that an apparatus is self-monitoring or self adjusting”.
This is a powerpoint of automation in clinical chemistry. This comprises the definition of automation, steps of the analytical process, and detail about the continuous flow analyzer.Thus, this will be helpful for the students of medical laboratory, biochemistry students and teachers.
Introduction of Automation of the Analytical Process
Unit Operations
Specimen identification
Specimen preparation
Specimen delivery
Specimen loading and aspiration
Specimen processing
Sample induction and internal transport
Reagent handling and storage
Chemical reaction phase
Measurement approaches
Signal processing, data handling and process control
Applications of automation in clinical lab
Chemiluminescence Immunoassay (CLIA) using Microplate luminometers provides a sensitive, high throughput, and economical way to quantitatively measure antigen in cell lysates, plasma, urine, saliva, tissue and culture media samples.
Chemiluminescence Immunoassay does not require long incubations and the addition of stopping reagents, as is the case in conventional colorimetric assays such as Enzyme-linked ImmunoSorbent Assays (ELISA).
Among various enzyme assays that employ light-emitting reactions, one of the most successful assays is the enhanced chemiluminescent immunoassay involving a horseradish peroxidase (HRP) labeled antibody or antigen and a mixture of chemiluminescent substrate, hydrogen peroxide, and enhancers.
In recent years, CLIA has become very popular in clinical chemistry and environmental analysis, due to its high sensitivity, wide dynamic range and complete automation. With the development and application of recombinant Ab (rAb) technology, markers and related techniques, solid-phase materials and improvements in automation, integration and miniaturization, CLIA has acquired an entirely new appearance.
Introduction of Automation of the Analytical Process
Unit Operations
Specimen identification
Specimen preparation
Specimen delivery
Specimen loading and aspiration
Specimen processing
Sample induction and internal transport
Reagent handling and storage
Chemical reaction phase
Measurement approaches
Signal processing, data handling and process control
Applications of automation in clinical lab
Chemiluminescence Immunoassay (CLIA) using Microplate luminometers provides a sensitive, high throughput, and economical way to quantitatively measure antigen in cell lysates, plasma, urine, saliva, tissue and culture media samples.
Chemiluminescence Immunoassay does not require long incubations and the addition of stopping reagents, as is the case in conventional colorimetric assays such as Enzyme-linked ImmunoSorbent Assays (ELISA).
Among various enzyme assays that employ light-emitting reactions, one of the most successful assays is the enhanced chemiluminescent immunoassay involving a horseradish peroxidase (HRP) labeled antibody or antigen and a mixture of chemiluminescent substrate, hydrogen peroxide, and enhancers.
In recent years, CLIA has become very popular in clinical chemistry and environmental analysis, due to its high sensitivity, wide dynamic range and complete automation. With the development and application of recombinant Ab (rAb) technology, markers and related techniques, solid-phase materials and improvements in automation, integration and miniaturization, CLIA has acquired an entirely new appearance.
Food borne pathogens causes various diseases. So it is very important to detect them. Rapid methods help to detect pathogens in a very short period of time.
i am HAFIZ M WASEEM from mailsi vehari
BSc in science college Multan Pakistan
MSC university of education Lahore Pakistan
I love Pakistan and my teachers
This content is suitable for medical technologists/technicians/lab assistants/scientists writing the SMLTSA board exam. The content is also suitable for biomedical technology students and people also interested in learning about test methodologies used in medical technology. This chapter describes test methodologies and their uses. Please note that these notes are a collection I used to study for my board exam and train others who got distinctions using these.
Disclaimer: Credit goes to those who wrote the notes and the examiners of each exam question. Please use only as a reference guide and use your prescribed textbook for the latest and most accurate notes and ranges. The material here is not referenced as it is a collection of pieces of study notes from multiple people, and thus will not be held viable for any misinterpretations. Please use at your own discretion.
technique of preparing imprint smear# comparision with frozen sections# application and its role in thyroid ,paathyroid,breast,skin,head and neck and mucinous tumors# advantages and limitations
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
3. HISTORY
• WEIDMANN (1888) introduced the term Luminescence(weak glow)
• Defined it as
A phenomenon of certain kind of substance emitting light on absorbing
the various energies without heat generation .
4/5/2022 3
4. LUMINESCENCE
• Luminescence is described as emission of cold light at lower
temperature .
• It is emitted from a substance as it returns from an electronically
excited state to ground state.
• Various forms of Luminescence:
• 1)Chemiluminescence
• 2)Electroluminescence
• 3)Bioluminescence
4/5/2022 4
7. PRINICIPLE OF CHEMI LUMINESCENCE
• Luminescence is described as emission of light from a substance as it
returns from an electronically excited state to ground state.
• For chemical luminescence it is light produced by a chemical reaction
• The substance can be excited by oxidation reaction.
4/5/2022 7
9. CHEMILUMINESCENCE
• Emission of light with limited emission of heat as a result of chemical
reaction
• A + B C (PRODUCT + LIGHT)
• A,B are reactants
• C= excited intermediate
4/5/2022 9
10. • For example A is luminol and B is hydrogen peroxide in the presence
of suitable catalyst we get
• Luminol + H2O2 =3 APA ( ) =3-APA + LIGHT
• Where
• 3-APA is aminophthalate
• 3 –APA ( ) Is the excited state producing light as it decays to a lower
energy level
4/5/2022 10
11. CRITERIA FOR SUCCESSFUL
CHEMILUMINISCENT REACTION
• Sufficient excitation energy provided for chemical reaction for red
emissionis 47.6 kcal/mol and blue emission is 63.5kcal/mol.
• The liberation of this much energy usually comes from bond
cleavage or electron transfer.
• Formation of products capable of forming an excited state multiple
bonds ,conjugation.
• Rapid kinetics( rate is imp than high yield)
4/5/2022 11
12. • Luminescent reactions usually involves the cleavage or fragmentation
of O-O bond an organic peroxide compound.
• Peroxides are prevalent in light emitting reaction because the relative
weak bond in easily cleaved and liberates large amount of energy.
• In order to achieve highest level of sensitivity a reaction must be as
efficient as possible in generating photons of light.
4/5/2022 12
13. • CL REACTION CAN BE GENERATED BY TWO BASIC MECHANISMS
In a DIRECT REACTION, two reagents, usually a substrate and an
oxidant in presence of some co-factor, react to form a product, then some
fraction of the product will be formed in an electronically excited state
which can subsequently relax to the ground state with emission of a photon.
4/5/2022 13
14. • INDIRECT REACTION is based on a process of transference of energy of the
excited species to a fluorophore.
• This process makes it possible for those molecules that are unable to be directly
involved in CL reactions to transfer their excess of energy to a fluorophore that in
turn is excited, releasing to its ground state with photon emission.
4/5/2022 14
15. • CHEMILUMINESCENT METHODS
• direct—using luminophore markers
• indirect—using enzyme markers.
• Either method may be competitive or non-competitive.
• In direct chemiluminescent methods, the luminophore markers used are
acridinium and ruthenium esters.
4/5/2022 15
16. • The enzymatic markers used in indirect methods .
• alkaline phosphatase with adamantyl 1, 2-dioxetane aryl phosphate
(AMPPD) substrate and horseradish peroxidase with luminol or its
derivatives as substrate.
• Synthesizing molecules such as AMPPD and isoluminol base molecule
derivatives are more stable and result in light emission with a
characteristically elevated quantum yield.
4/5/2022 16
17. • The addition of an enhancer (e.g. ferrocyanide, metallic ions) further
boosts the electronic activation, ultimately leading to extremely
elevated analytic sensitivity (mol−16 per litre).
• certainly superior to those attainable by other immunoassay methods
such as RIA, immune enzymatic (ELISA) and fluoro immune
enzymatic (FEIA) methods etc.
4/5/2022 17
18. APPLICATIONS OF CHEMILUMINESCENCE
• Chemiluminescence immunoassay
• DNA hybridization detection
• Forensic science
• Food analysis
4/5/2022 18
19. CHEMILUMINESCENCE IMMUNOASSAY
• Provides a sensitive high through output alternative to conventional
colorimetric methodologies.
• PRINCIPLES
• Same as ELISA
• Uses chemiluminescent substrate, hydrogen peroxide ,enhancers
• Stopping reagent is not required
• Incubation period is small
4/5/2022 19
20. PROCEDURE
• MONOCLONAL ANTIBODY COATED WELL
• TEST SPECIMEN
• HRP LABELLED ANTIBODY CONJUGATE
• TEST ANTIGEN; SANDWICH BETWEEN SOLID PHASE ANTIBODY
AND ENZYME LABELLED ANTIBODY
4/5/2022 20
21. • INCUBATE FOR 1 HR AT 37C
• REMOVE UNBOUND ENZYME LABELLED ANTIBODY
• CHEMILUNESCENCE REAGENT ADDED
• READ RELATIVE LIGHT UNIT WITH LUMINOMETER
4/5/2022 21
23. labels
• Reagents required for reactions that produce CL may be coupled to
Abs or antigens (Ags) and used as labels for IA.
• This category involves labels that are consumed in the CL analytical
reaction (e.g., luminol derivatives, acridinium esters).
4/5/2022 23
24. • Luminol is the best known and one of the most efficient CL reagents.
It is coupled to ligands via reactions involving the amino group.
• However, the resulting conjugates have lower CL efficiencies than the
parent compounds. Labels derived from isoluminol have been more
successful.
4/5/2022 24
25. • SOLID-PHASE MATERIALS
Commonly used solid-phase are 96-well microtitration plates prepared
with Polystyrene.
For the purposes of IA, the microplates are pre-coated with capturing
protein like Ab to allow analyte immobilization.
4/5/2022 25
26. • IMMUNOASSAY
• Chemiluminescent immunoassay test kits and automated immunoassay
analyzers have been developed.
• The analysers routinely measured in a clinical chemistry, immunology,
toxicology, virology and endocrinology laboratories for the assessment
of :
4/5/2022 26
27. Clinical utilities
Thyroid Tumor markers Anemia Harmones Drug monitoring
Anti TPO
Anti TG
Free T3
Free T4
Total T3
Total T4
TSH
AFP
CA 125H
CA 19-9
CEA
PSA
Serum HER 2 NEU
Ferritin
Vitamin b12
CARDIAC
BNP
CKMB
D DIMER
FSH
LH
HcG
Progesterone
Prolactin
Testosterone
Carbamazepine
Digoxin
Gentamycin
Phenytoin
Theophylline
Valproic acid
Vancomycin
Cyclosporine
4/5/2022 27
28. The three major chemiluminescent
technologies
1. Acridinium ester and sulphonamide labels in chemiluminescent
immunoassays
2. Chemiluminescent detection techniques for horseradish peroxidase labels
3. Chemiluminescent detection techniques for alkaline phosphate labels in
enzyme immunoassays.
4/5/2022 28
29. NUCLEIC ACID ASSAYS
• The first major success of chemiluminescence in nucleic acid testing
with non separation chemiluminescent hybridization protection assay
for detecting specific DNA or RNA sequences.
• This type of chemiluminescent test is now widely used test for
infectious agents (e.g. chlamydia)
4/5/2022 29
30. CLINICAL RESEARCH
• In clinical research sensitivity, dynamic range and diversity of
chemiluminescent assays has lead to a vast range of applications notably in
Immunoassays
Protein and nucleic acid blotting
Microarray- based assays
4/5/2022 30
31. • Monitoring reactive oxygen species and as detection reactions for
substances separated by HPLC
• Capillary electrophoresis ( CE) and
• Flow- injection analysis.
4/5/2022 31
32. RESEARCH IMMUNOASSAY
• A large number of research immunoassays and emerging clinical tests have been
developed in chemiluminescent format e.g.
cytokines (IL-4, IL-5, IL-6, IL-10)
Endothelin-1
Epidermal growth factors
50 granulocyte colony- stimulating factor
Interferon
vascular endothelial growth factor c
4/5/2022 32
33. • The luminescent oxygen channeling immunoassay (LOCI) exploits the
in situ production of a chemiluminescent compound due to single
oxygen transfer between a donor and acceptor antibody coated
microbead (250nm diameter) brought in to contact as a result of
specific binding with the test agent.
4/5/2022 33
34. • This assay has been adopted for competition assays
• Interaction assay( ligand/receptor, protein/protein, protein/ DNA)
• Enzyme assays (e.g protease, kinase, helicase)
• Immunoassays( thyrotropin, hepatitis B surface antigen, digoxin).
4/5/2022 34
35. • The LOCI- type assay is also used for nucleic acid assays, example
• Single nucleotide polymorphism typing
• Nucleic acid amplification techniques such as the polymerase chain reaction
• Lassa fever virus( reverse transcriptase polymerase chain reaction method)
papilloma virus in cervical scrapes.
4/5/2022 35
36. BLOTTING TECHNIQUES
• WESTERN BLOTTING for proteins using gel electrophoresis
Southern blotting for DNA
Northern blotting for RNA.
4/5/2022 36
37. GENE- BASED ASSAYS
• A successful research application for chemiluminescence is detecting the
expressed products of the reporter genes developed as alternatives to the
traditional methods like detecting chloramphenicol acetyl transferase (CAT)
gene.
• It is also used to detect and quantitate expression products of genes for placental
alkaline phosphatase(PLAP), galactosidase(GAL), and glucuronidase(GUS).
4/5/2022 37
38. CELLULAR CHEMI LUMINESCENCE
• The cellular chemi luminescence studies includes investigations /detecting-
• human spermatozoa
• defects in the production of reactive oxygen intermediates
• response of cells (e.g. PMN-leukocytes, neutrophils) to drugs and different agents
• Complement receptors
• Polyunsaturated fatty acids ,lectins, endotoxins, H PYLORI lipopolysacharides
4/5/2022 38
39. Advantages and limitations of CLIA technology
• The key advantages of chemiluminescent analytical methods
• Wide dynamic range
• High signal intensity
• Absence of interfering emissions (i.e. high specificity)
• Rapid acquisition of the analytical signal
4/5/2022 39
40. • high stability of reagents and their conjugates
• Low consumption of reagents
• Random access
• Reduced incubation time and full compatibility with immunology
assay protocols (homogenous or non-homogenous).
4/5/2022 40
41. • DISADVANTAGES OF CLIA
• Limited Ag detection
• High costs
• Limited tests panel
• Closed analytical systems.
4/5/2022 41
42. CHEMILUMINESCENT ASSAYS AND FOR ANALYSIS IN BODY FLUIDS
• Urinary N-acetyl-d-glucose aminidase
• Cholesterol
• Vitamin C
• Blood spot screening tests for phenyl ketonuria (PUK)
• Galactossemia and maple syrup urine disease.
4/5/2022 42
43. • Chemi luminescence is also useful in detection reactions for
components of mixtures separated by techniques such as
• HPLC
• Capillary electrophoresis
• Flow injection.
4/5/2022 43
44. DNA HYBRIDIZATION
• STEPS IN HYBRIDIZATION
• Process of forming double stranded DNA molecule between a single
stranded DNA probe and single stranded targeted DNA.
• The restriction fragments present in the gel are denatured with alkali
and transferred on to nitrocellulose filter or nylon membrane by
blotting
• This procedure preserves the distribution of the fragments in the gel
creating a replica of the gel on the filter paper.
4/5/2022 44
45. • The filter is incubated under hybridization conditions with a HRP
labelled DNA probe.
• The probe hybridize to the complimentary DNA restriction fragment
• Detection reagent containing H2O2and luminol is added on to the
membrane.
• USES:
• Identifying DNA in crime case
• Paternal dispute
• Classify DNA of various organism
4/5/2022 45
47. FORENSIC SCIENCE
• It is used by criminalists to detect traces of blood at crime scene.
• Solution luminol powder ,hydrogen peroxide are sprayed where blood
might be found.
• Tiny amount of iron from Hb in blood serves as catalyst for the
chemiluminiscence reaction, luminol to glow.
4/5/2022 47
50. OTHER APPLICATIONS
• GAS ANALYSIS-to determine small amount of impurities and poisons in
air
• Other compounds such as ozone, S compounds , fluxes of -oxide
compounds .
• Lightening objects, chemiluminescent kites, glow stick, emergency
lightenings
• Children toys
• COMBUSTION ANALYSIS-certain radical species (CH+ AND OH+) gives off
radiation at specific wavelengths .
4/5/2022 50
51. ENHANCED CHEMILUMINESCENCE
• It is common technique for variety of detection assays
• A horse radish peroxide enzyme is tethered to antibody that
specifically recognises the molecule of interest.
• This enzyme complex then catalyse the conversion of enhanced
substrate into sensitised reagent .
• Which on further oxidation by H2O2 produces a triplet carbonyl
which emits light when it reduced to single carbonyl
4/5/2022 51
52. • It allows the minute quantities of biomolecules detection in femto
litres
• It is characterised by following features
• Intense light emission
• Prolong emission of light no pre incubation step
• Substrate that can be added several minutes prior to detection
• As long as commercially preparations of luminal are used control of
reaction PH is not a concern
4/5/2022 52
54. ELECTROCHEMICAL LUMINESCENCE
• In this process electro chemically generated intermediates undergo
highly exogonic reaction to produce electronically excited state .
• Emits light upon relaxation to lower state.
• ECL excitation can be caused by redox reaction of electron generated
species.
• It is observed during application of potential to electrodes of
electrochemical cell that contains solution of luminescent species
(metal complexes, quantum dots) in aprotic organic solvents.
4/5/2022 54
55. • The excitation energy is obtained from recombination of oxidised and
reduced species .
• The luminescent species are oxidised at electrode together with co
reactant which gives strong reducing agent after some chemical
transformation.
• It generally uses ruthenium complexes regenerating with TPrA
(tripropylamine) in liquid phase
• Photon detection is done in photo multiplier tubes or silicon photo
diodes.
4/5/2022 55
56. • It is highly sensitive and specific method.
• It present with outstanding advantage over other methods
• versatility
• simplified optical setup compared with photo luminescence
• good temporal control.
4/5/2022 56
59. LIMITATONS
• Light leaks from light pumpings
• Reagent/solvent purity
• High background luminescence from reagents and reactions
• Extreme sensitivity of chemiluminescence
4/5/2022 59
60. CONCLUSION
• Chemiluminescent methods are now well established in routine
clinical analysis and as tools in clinical and biomedical research.
• Many clinical laboratories preform routine immunoassay and nucleic
acid testing and research applications.
4/5/2022 60
61. References
• Campbell, A K. Chemiluminescence. Principles and applications in biology and
medicine. Germany: N. p., 1988. Web.
• C. Dodeigne, L. Thunus, R. Lejeune, Chemiluminescence as diagnostic tool. A
review, Talanta, Volume 51, Issue 3, 2000, Pages 415-439.
• ixia Zhao, Li Sun, Xiaogang Chu, Chemiluminescence immunoassay,TrAC Trends
in Analytical Chemistry, Volume 28, Issue 4,2009,Pages 404-415.
• L.J Kricka,Clinical applications of chemiluminescence,Analytica Chimica Acta,
Volume 500, Issues 1–2, 2003, Pages 279-286.
4/5/2022 61